Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 28, 2020
Genomic Alteration in Metastatic Breast Cancer and Its Treatment
Allen Li, Stephen M Schleicher, Fabrice Andre, et al.
Cancers
|
April 14, 2026
The Evolution of Targeted Therapies in Early Hormone Receptor-Positive, HER2-Negative Breast Cancer
Hyejee Ohm, Caroline Lohrisch, Nathalie LeVasseur, et al.
NPJ Precision Oncology
|
June 13, 2025
Utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer
Daniel Bottomly, Christina Zheng, Allison L Creason, et al.
The Oncologist
|
November 24, 2020
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy
Madeline M Cook, Luai Al Rabadi, Andy J Kaempf, et al.
BMC Cancer
|
October 28, 2021
Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab
Luai S Al Rabadi, Madeline M Cook, Andy J Kaempf, et al.
NPJ Precision Oncology
|
September 9, 2022
Impact of TP53 mutations in Triple Negative Breast Cancer
Zahi I Mitri, Nour Abuhadra, Shaun M Goodyear, et al.
The Oncologist
|
March 22, 2023
Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Malinda T West, Shaun M Goodyear, Evthokia A Hobbs, et al.
The Oncologist
|
May 8, 2015
BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing
Zahi I Mitri, Michelle Jackson, Carolyn Garby, et al.
Nutrients
|
November 14, 2023
Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor
Duygu Altinok Dindar, Brie Chun, Amy Palma, et al.
NPJ Precision Oncology
|
March 27, 2021
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
Allen Li, Jamie M Keck, Swapnil Parmar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 28, 2020
Genomic Alteration in Metastatic Breast Cancer and Its Treatment
Allen Li, Stephen M Schleicher, Fabrice Andre, et al.
Cancers
|
April 14, 2026
The Evolution of Targeted Therapies in Early Hormone Receptor-Positive, HER2-Negative Breast Cancer
Hyejee Ohm, Caroline Lohrisch, Nathalie LeVasseur, et al.
NPJ Precision Oncology
|
June 13, 2025
Utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer
Daniel Bottomly, Christina Zheng, Allison L Creason, et al.
The Oncologist
|
November 24, 2020
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy
Madeline M Cook, Luai Al Rabadi, Andy J Kaempf, et al.
BMC Cancer
|
October 28, 2021
Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab
Luai S Al Rabadi, Madeline M Cook, Andy J Kaempf, et al.
NPJ Precision Oncology
|
September 9, 2022
Impact of TP53 mutations in Triple Negative Breast Cancer
Zahi I Mitri, Nour Abuhadra, Shaun M Goodyear, et al.
The Oncologist
|
March 22, 2023
Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Malinda T West, Shaun M Goodyear, Evthokia A Hobbs, et al.
The Oncologist
|
May 8, 2015
BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing
Zahi I Mitri, Michelle Jackson, Carolyn Garby, et al.
Nutrients
|
November 14, 2023
Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor
Duygu Altinok Dindar, Brie Chun, Amy Palma, et al.
NPJ Precision Oncology
|
March 27, 2021
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
Allen Li, Jamie M Keck, Swapnil Parmar, et al.
Page
of 2